Schedule 13G ownership disclosure

ALAUNOS THERAPEUTICS INC

Common Stock, $0.001 par value per share · CUSIP: 98973P309

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MSD Partners, L.P.

    Shares: 0 · Class: 0%

  • MSD Credit Opportunity Master Fund, L.P.

    Shares: 0 · Class: 0%

  • Gregg R. Lemkau

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-019905
Form type
SCHEDULE 13G/A
Filer
Alaunos Therapeutics, Inc.
CIK
CIK 1107421
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub